🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could result in individuals administering substances of uncertain source.

Some experts stated the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.

Platform Response and Material Elimination

Based on TikTok, the service has taken down problematic content and banned associated keywords and query recommendations. The company said it was dedicated to keeping the service secure and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Investigations also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, populated with photos of weight loss, positive testimonials and detailed instructions for preparing or administering at home.

Within moments of entering one group, a seller shared contact information, where most purchases take place. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, health issues or past usage.

Item Information and Pricing

Inside these groups, messages show dark colored packages with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service said it regularly moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they cannot confirm. Although the research behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has already seen patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental substance not yet approved … may expose patients to possibly serious medical dangers”.